Differentiating PD from MSA

Differentiating PD from MSA
  There is a lot of clinical and biological similarities between the neurodegenerative conditions of Parkinson’s and multiple systems atrophy (or MSA). Recently, however, researchers have published a report suggesting that these two conditions may be differentiated from each other using a technique ... read more
Source: The Science of Parkinson’s diseasePublished on 2020-02-19By Simon

Related Articles:

  • Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy. July 30, 2019 Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy. Continuum (Minneap Minn). 2019 Aug;25(4):919-935 Authors: Greene P Abstract PURPOSE OF REVIEW: Patients who have parkinsonian features, especially without tremor, that are not responsive to levodopa, usually have one of these three major neurodegenerative disorders rather than Parkinson disease: progressive supranuclear palsy (PSP), multiple system atrophy (MSA), or corticobasal degeneration (CBD).…
  • Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. July 11, 2019 Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain. 2019 Jul 09;: Authors: Miki Y, Foti SC, Asi YT, Tsushima E, Quinn N, Ling H, Holton JL Abstract Clinical diagnosis of multiple system atrophy is challenging and many patients with Lewy body disease (i.e. Parkinson's disease or dementia with Lewy bodies) or progressive supranuclear palsy are misdiagnosed as…
  • Quantitative susceptibility mapping in atypical Parkinsonisms. September 21, 2019 Quantitative susceptibility mapping in atypical Parkinsonisms. Neuroimage Clin. 2019 Aug 31;24:101999 Authors: Mazzucchi S, Frosini D, Costagli M, Del Prete E, Donatelli G, Cecchi P, Migaleddu G, Bonuccelli U, Ceravolo R, Cosottini M Abstract BACKGROUND AND PURPOSE: Differential diagnosis between Parkinson's disease (PD) and Atypical Parkinsonisms, mainly Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA), remains challenging. The low…
  • Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy. August 14, 2019 Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy. Transl Neurodegener. 2019;8:24 Authors: De Luca CMG, Elia AE, Portaleone SM, Cazzaniga FA, Rossi M, Bistaffa E, De Cecco E, Narkiewicz J, Salzano G, Carletta O, Romito L, Devigili G, Soliveri P, Tiraboschi P, Legname G, Tagliavini F, Eleopra R, Giaccone…
  • Dyskinesia in multiple system atrophy and progressive supranuclear palsy. May 16, 2019 Related ArticlesDyskinesia in multiple system atrophy and progressive supranuclear palsy. J Neural Transm (Vienna). 2019 May 13;: Authors: Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A Abstract In the differential diagnosis of Parkinson syndromes, the response to L-Dopa is an essential criterion for the diagnosis of idiopathic Parkinson's syndrome (IPS), and the presence of…
  • Multiple system atrophy mimicked by multi-organ pathology. April 13, 2019 Related ArticlesMultiple system atrophy mimicked by multi-organ pathology. Pract Neurol. 2019 Apr 11;: Authors: Khan S, Sivakumar G, Currie S, Alty J Abstract Both multiple system atrophy and Parkinson's disease may present with parkinsonism and autonomic dysfunction. We describe a patient who initially met the diagnostic criteria for multiple system atrophy and had atypical features for Parkinson's disease including blackouts…
  • Patients with IBD at Increased Risk of Parkinson’s, ‘Real Life’ Study Suggests May 30, 2018 Patients with inflammatory bowel disease (IBD) are at an increased risk of developing Parkinson’s disease, a new study suggests. The research, “Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014,” was published in the journal Gut. Inflammation plays a key role in the development of Parkinson’s and multiple system atrophy (MSA), two conditions that belong…
  • 3P - Post Doc Seminar - 14 May May 7, 2020 On Thursday the 14th of May join 3P Seminars for our “Multiple system atrophy (MSA)” themed session, as Raphaella So, PhD student at University of Toronto, presents on “Studying alpha-synuclein diseases in the context of conformational strains” and MSA patient advocate Beverly K. Wilson, discusses “Extraordinarily Healthy! . . . except for MSA”. Raphaella’s presentation will present the following: Like…
  • Differential Diagnosis Of Multiple-System Atrophy With Parkinson's Dis | NDT - Dove Medical Press November 5, 2019 Differential Diagnosis Of Multiple-System Atrophy With Parkinson's Dis | NDT  Dove Medical Press
  • Parkinson’s Patients Without Cognitive Impairment Have Normal Life Expectancy, Study Suggests November 5, 2018 While patients with some types of parkinsonism have a shorter lifespan, those with Parkinson’s disease without cognitive impairment have a normal life expectancy, a Swedish population-based study suggests. The study, “Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study,” was published in the journal Neurology. Studies have shown that life expectancy for Parkinson’s patients is reduced. However, conflicting data exists…
  • Differential diagnosis of multiple system atrophy with predominant parkinsonism and Parkinson's disease using neural networks. April 22, 2019 Related ArticlesDifferential diagnosis of multiple system atrophy with predominant parkinsonism and Parkinson's disease using neural networks. J Neurol Sci. 2019 Apr 11;401:19-26 Authors: Tsuda M, Asano S, Kato Y, Murai K, Miyazaki M Abstract Differential diagnosis between Parkinson's disease (PD) and atypical parkinsonism, such as multiple system atrophy (MSA), can be difficult, especially in the early stages of the disease.…
  • Researcher's technology differentiates between Parkinson's disease and multiple system atrophy February 5, 2020 Scientists have found a way to distinguish between two progressive neurodegenerative diseases, Parkinson's disease (PD) and multiple system atrophy (MSA), using a technology developed by a researcher at The University of Texas Health Science Center at Houston (UTHealth). The discovery was published today in Nature.
  • Not Easy for EGCG July 8, 2019 This week the results of the PROMESA (Progression Rate Of Multiple system atrophy under EGCG Supplementation as Anti-aggregation-approach) study were published. The PROMESA study was a clinical trial evaluating the impact of an experimental treatment called Epigallocatechin-gallate (or EGCG) on the progression of symptoms in people with Multiple System Atrophy (or MSA). MSA is a condition very similar to Parkinson's…
  • Parkinson’s vs. Parkinsonism January 8, 2020 What do Michael J. Fox, Muhammad Ali, Alan Alda, Former President Bush, Neil Diamond, and professional cyclist Davis Phinney all have in common? They all have or had different types of parkinsonism of which Parkinson’s is one kind.  Parkinson’s vs. Parkinsonism Parkinsonism, also called atypical Parkinson’s or Parkinson’s plus, is the umbrella term used to describe a group of neurological…
  • Researchers begin trial of drug to slow progression of neurodegenerative condition Multiple System Atrophy - BioSpace October 22, 2019 Researchers begin trial of drug to slow progression of neurodegenerative condition Multiple System Atrophy  BioSpace
  • Researcher's technology differentiates between Parkinson's disease and multiple system atrophy February 5, 2020 Scientists have found a way to distinguish between two progressive neurodegenerative diseases, Parkinson's disease (PD) and multiple system atrophy (MSA), using a technology developed by a researcher ...
  • Structural Differences Seen in Toxic Proteins Marking Parkinson’s, Multiple System Atrophy February 10, 2020 Assessing the shape of alpha-synuclein aggregates in the brain helps to distinguish between Parkinson’s disease (PD) and another progressive neurodegenerative disorder known as multiple system atrophy (MSA), a study suggests. The study, “Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy,” was published in Nature. Parkinson’s and MSA share many symptoms, particularly in earlier disease stages. This often leads to misdiagnoses,…
  • Quantitative autonomic function test in differentiation of multiple system atrophy from idiopathic Parkinson disease. August 3, 2019 Quantitative autonomic function test in differentiation of multiple system atrophy from idiopathic Parkinson disease. Chin Med J (Engl). 2019 Aug 01;: Authors: Park JY, Yang D, Yang HJ, Kim HA, Kim S, Heo D, Park JH, Lee ES, Lee TK Abstract BACKGROUND: Differential diagnosis of idiopathic Parkinson disease (IPD) and multiple system atrophy-Parkinson type (MSA-P) is challenging since they share…
  • α-Synuclein strains in multiple system atrophy: A product of their environment? September 20, 2018 α-Synuclein strains in multiple system atrophy: A product of their environment? Mov Disord. 2018 Aug;33(8):1270 Authors: Breen DP, Fasano A PMID: 30230622 [PubMed - in process]
  • Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study. June 11, 2019 Related ArticlesCerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study. Parkinsonism Relat Disord. 2019 Jun 03;: Authors: Compta Y, Dias S, Giraldo DM, Pérez-Soriano A, Muñoz E, Saura J, Fernández M, Bravo P, Cámara A, Pulido-Salgado M, Painous C, Ríos J, Martí MJ, CMSAR consortium Abstract INTRODUCTION: Neuroinflammation is a potential player in neurodegenerative conditions, particularly…